Advertisement
Advertisement
Penumbra, Inc. (Neuro)
1351 Harbor Bay Parkway, Alameda, CA 94502
PHONE: (510) 748-3200 | FAX: (510) 748-3232
Catheters / Guiding Catheters
View Chart| Company Name | Product Name | Type | Size (F) | Length (cm) | Internal Diameter (inch) | Radiopaque Tip (Yes/No) | Hydrophilic Coated |
|---|---|---|---|---|---|---|---|
| Penumbra, Inc. (Neuro) | 6F Select Catheter | Braid reinforced | 5 (distal), 5.6 (proximal) | 105, 125 | 0.040 | Radiopaque distal shaft | No |
| Penumbra, Inc. (Neuro) | Benchmark 071 Intracranial Access Kit | Coil reinforced | 6 | 95, 105, 115 | 0.071 | Yes, distal shaft plus markerband | Yes |
| Penumbra, Inc. (Neuro) | Benchmark BMX81 Access System | Laser-cut stainless steel hypotube | 7 | 95, 105, 115 | 0.081 | Yes, full shaft plus markerband | Yes, 18 cm |
| Penumbra, Inc. (Neuro) | Benchmark BMX96 Access System | Laser-cut stainless steel hypotube | 8 | 80, 90, 100 | 0.096 | Yes, distal shaft plus markerband | Yes |
| Penumbra, Inc. (Neuro) | Neuron MAX 088 Delivery Catheter | Braid/coil reinforced | 8 | 80, 90, 100 | 0.088 | Yes, distal shaft plus markerband | Yes |
| Penumbra, Inc. (Neuro) | Midway 43 Delivery Catheter | Intermediate catheter | 4-F compatible OD | 115, 125 | 0.043 | Yes, markerband | Yes, 60 cm |
| Penumbra, Inc. (Neuro) | Midway 62 Delivery Catheter | Intermediate catheter | 5-F Compatible OD | 115, 125 | 0.062 | Yes, markerband | Yes, 30 cm |
| Penumbra, Inc. (Neuro) | 5F Select Catheter | Braid reinforced | 5 (distal), 5.5 (proximal) | 120, 130 | 0.040 | Yes, radiopaque distal shaft | No |
Advertisement
Advertisement
Embolization / Cerebral Coils
View Chart| Company Name | Product Name | Materials Used | Coil Type | Method of Detachment | US FDA Indicated Use | Comments |
|---|---|---|---|---|---|---|
| Penumbra, Inc. (Neuro) | PAC400 Coil | Stretch-resistant bare platinum | – | Instant mechanical detachment | Indicated for the embolization of intracranial aneurysms, other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae, and arterial and venous embolizations in the peripheral vasculature | A soft coil designed to pack densely behind/within a POD400/PC400 backstop |
| Penumbra, Inc. (Neuro) | SwiftSET | Stretch-resistant bare platinum | Complex, vessel sacrifice coil | Instant mechanical detachment | Indicated for the embolization of intracranial aneurysms, other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae, and arterial and venous embolizations in the peripheral vasculature | Complex shape featuring closed-loops designed for stable anchoring and vessel conformity |
| Penumbra, Inc. (Neuro) | SwiftPAC | Stretch-resistant bare platinum | Shapeless packing coil | Instant mechanical detachment | Indicated for the embolization of intracranial aneurysms, other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae, and arterial and venous embolizations in the peripheral vasculature | Soft shapeless coil designed to pack densely, compatible with 0.0165-inch microcatheters |
| Penumbra, Inc. (Neuro) | POD400 Coil | Stretch-resistant bare platinum | Coil with distal anchor segment and proximal packing segment designed for vessel sacrifice | Instant mechanical detachment | Indicated for the embolization of intracranial aneurysms, other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistula, and arterial and venous embolizations in the peripheral vasculature | POD400 is designed to predictably anchor in vessels to create a reliable backstop |
| Penumbra, Inc. (Neuro) | Penumbra Smart Coil | Stretch-resistant bare platinum | Plus standard, standard, soft, extra soft, wave extra soft | Instant mechanical detachment | Indicated for the embolization of intracranial aneurysms, other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae, and arterial and venous embolizations in the peripheral vasculature | Embolization coil with complex and WAVE shapes, engineered with varying levels of softness |
| Penumbra, Inc. (Neuro) | Penumbra Coil 400 (PC400) | Stretch-resistant bare platinum | Complex standard, complex soft, curve extra soft, complex extra soft | Instant mechanical detachment | Indicated for the embolization of intracranial aneurysms, other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae, and arterial and venous embolizations in the peripheral vasculature | PC400 is a .020-inch coil designed for aneurysms and fistulas; comes in complex and helical shapes |
Other Devices / Mechanical Thrombectomy (Neurovascular)
View Chart| Company Name | Product Name | Sheath Compatibility (F) | Guidewire Compatibility (inch) | Working Length (cm) | Mode of Operation | US FDA Indicated Use |
|---|---|---|---|---|---|---|
| Penumbra, Inc. (Neuro) | 3D Revascularization Device | 6 (long sheath [Neuron MAX]) | 0.020 | 200 (delivery wire; compatible with Velocity Delivery microcatheter [160 cm] and 3MAX Reperfusion catheter [160 cm]) | Designed for use in combination with Reperfusion catheters; the architecture enables maximum clot capture capability through four intraluminal chambers and is optimized for use with aspiration delivered by ACE catheters or the Penumbra JET 7 Reperfusion catheter | As part of the Penumbra system, the Penumbra 3D Revascularization device is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral—M1 and M2 segments) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment. As part of the Penumbra system, the Penumbra 3D Revascularization device is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral—M1 and M2 segments) within 8 hours of symptom onset. Patients who are ineligible for thrombolytic drug therapy or who failed thrombolytic drug therapy are candidates for treatment |
| Penumbra, Inc. (Neuro) | Penumbra System Reperfusion Catheters: RED 72 SILVER LABEL, RED 72 SILVER LABEL with SENDit Technology, RED 68, RED 62, RED 43, Penumbra JET D, 4MAX, 3MAX, and 026 | 6 (RED 72 SILVER LABEL, RED 72 SILVER LABEL with SENDit Technology, RED 68, RED 62, RED 43, and Penumbra JET D require 8-F short sheath or 6-F long sheath) | 0.014–0.024 | 132–160 | Direct aspiration clot removal with Penumbra Engine aspiration source | As part of the Penumbra system, the Reperfusion catheters and separators are indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral—M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset; patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment; as part of the Penumbra system, the Reperfusion catheters and separators are indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral—M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset; patients who are ineligible for thrombolytic drug therapy or who failed thrombolytic drug therapy are candidates for treatment |
| Penumbra, Inc. (Neuro) | Penumbra System Separator and Separator Flex: 5MAX, 4MAX, 3MAX, and 026 | – | – | 175–200 (Separator and Separator Flex length) | Separator-assisted clot debulking, if needed | As part of the Penumbra system, the Reperfusion catheters and separators are indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral—M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment As part of the Penumbra system, the Reperfusion catheters and separators are indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral—M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for thrombolytic drug therapy or who failed thrombolytic drug therapy are candidates for treatment |
| Penumbra, Inc. (Neuro) | Penumbra Thunderbolt Aspiration Tubing: Thunderbolt | 6 (RED 72 SILVER LABEL, RED 72 SILVER LABEL with SENDit Technology, RED 68, and RED 62 require 8F short sheath or 6F long sheath. RED 43 is not compatible with THUNDERBOLT in Modulated Aspiration, but may be used within the Penumbra Reperfusion Catheter with THUNDERBOLT in Continuous Aspiration at the discretion of the physician) | 0.014–0.024 | 132–160 | The Penumbra Thunderbolt Aspiration Tubing is designed to serve as a conduit to assist in thrombus removal, facilitating the transfer of vacuum between the Penumbra Reperfusion Catheter (RED 62, RED 68, RED 72 SILVER LABEL, and/or RED 72 SILVER LABEL with SENDit Technology) and Penumbra Aspiration Pump while providing modulated or continuous aspiration; modulated aspiration is provided when the Penumbra Thunderbolt Aspiration Tubing alternates between connecting the Reperfusion Catheter to the Penumbra Aspiration Pump and a sterile saline intravenous (IV) bag at ambient pressure in a predetermined modulated aspiration sequence | As part of the Penumbra System, the Reperfusion Catheters and Separators are indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral – M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset; patients who are ineligible for thrombolytic drug therapy or who failed thrombolytic drug therapy are candidates for treatment; Penumbra Thunderbolt Aspiration Tubing: as part of the Penumbra System, the Penumbra Thunderbolt Aspiration Tubing is indicated to connect the Penumbra Reperfusion Catheters to the Penumbra Aspiration Pump; Penumbra Aspiration Pump: the Penumbra Aspiration Pump is indicated as a vacuum source for Penumbra Aspiration Systems |
Catheters / Microcatheters
View Chart| Company Name | Product Name | Type of Catheter Construction | Proximal Size (F) | Middle Size (F) | Distal Size (F) | Catheter Working Length (cm) | Catheter Endhole Diameter ID (inch) | Recommended Guidewire Size (inch) | Radiopaque Tip (Yes/No) | Hydrophilic Coating (Yes/No) |
|---|---|---|---|---|---|---|---|---|---|---|
| Penumbra, Inc. (Neuro) | Velocity Delivery Microcatheter | Nitinol coil reinforced; eight extrusion zones | 2.95 | – | 2.6 | 160 | 0.025 | 0.014 | Yes, one markerband | Yes |
| Penumbra, Inc. (Neuro) | PX Slim Microcatheter | Nitinol coil reinforced; eight extrusion zones; four tip shapes: straight, 45°, 90°, and 130° | 2.95 | – | 2.6 | 150 | 0.025 | 0.014 | Yes, two markerbands | Yes |
More Categories:
Aortic (AAA) Aortic (TAA) Balloons Catheters Embolization Sheaths Stents Wires Other Devices View AllAdvertisement